Inhibition of LRRK2-Rab10 Pathway Improves Secondary Brain Injury After Surgical Brain Injury in Rats
Leucine-rich repeat kinase 2 (LRRK2) is considered as a potential target for the treatment of Parkinson's disease. This protein is expressed in the brain and has been associated with various diseases and lysosomal maintenance. Rab10 is a member of the Rab protein GTPase family that has been recently...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2022-01-01
|
| Серія: | Frontiers in Surgery |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fsurg.2021.749310/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|